Navigation Links
'Modern Healthcare' Names Marshall Erdman Nation's Top Design-Build Company

CHARLOTTE, N.C., March 27 /PRNewswire-FirstCall/ -- Marshall Erdman & Associates (Erdman) was rated the nation's top design-build company by "Modern Healthcare's" 2008 Construction & Design Survey. The survey compares design- build companies serving the healthcare industry; it examines year-over-year sales, contracted square footage fluctuations, and attributes such as years in business and number of architects, engineers and interior designers.

Erdman strictly operates in the healthcare arena, offering advanced planning, developing, designing, and building services. In 2007, the company reported completed healthcare construction totaling more than $300 million, an annual increase of more than 50 percent.

According to Scott Ransom, President and Chief Executive Officer of Erdman, "We are pleased to be recognized by "Modern Healthcare" as an industry leader. Erdman's growth reflects the fact that we take the time to understand our clients' vision and offer seamless coordinated business solutions. Erdman has a strong foundation for continued growth."

On March 10, 2008, Erdman became a part of Cogdell Spencer Inc., creating the most integrated healthcare real estate company in the nation.

About Cogdell Spencer Inc.

Charlotte-based Cogdell Spencer Inc. (NYSE: CSA) is a fully-integrated, self-administered and self managed real estate investment trust (REIT) that invests in specialty office buildings for the medical profession, including medical offices, ambulatory surgery and diagnostic centers. At present, the Cogdell Spencer Inc. portfolio consists of 61 wholly owned properties and consolidated joint ventures, three unconsolidated joint venture properties and 53 managed medical office buildings. On March 10, 2008, Cogdell Spencer Inc. merged with Marshall Erdman & Associates. As the leader in healthcare design- build, with over 5,000 facilities across the United States, Erdman brings a new range of offerings to Cogdell Spencer's clients. Welcome to the new Cogdell Spencer Inc. For more information on Cogdell Spencer Inc., please visit the Company's website at . For more information on Marshall Erdman & Associates, please visit .

Forward-Looking Statements

This document contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The forward-looking statements reflect the Company's views about future events and are subject to risks, uncertainties, assumptions and changes in circumstances that may cause actual results to differ materially. Factors that may contribute to these differences include, but are not limited to the following: market trends; our ability to obtain future financing arrangements; our ability to renew ground leases; defaults by tenants; and changes in the reimbursement available to our tenants by government or private payors. For a further list and description of such risks and uncertainties, see the reports filed by the Company with the Securities and Exchange Commission, including the Company's Form 10-K for the year ended December 31, 2007. Although the Company believes the expectations reflected in such forward-looking statements are based on reasonable assumptions, it can give no assurance that its expectations will be realized. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

SOURCE Cogdell Spencer Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Martopia(R) Forms Strategic Alliance With Modern Healthcare Magazine
2. Aromatherapy Gift Line Sheds Humorous Light on Modern Therapy
3. On 30th Anniversary, Angioplasty Celebrated as Modern Medical Breakthrough in Stopping Heart Attack
4. Canadas government funds $1.6M in modern geography to support public health decisions
5. Medical Imaging Revolutionizes Modern Medicine
6. Medicare modernization act did not change chemotherapy as feared
7. Modernizing and Improving the Disability and Compensation Systems
8. Video: What Modern Girls Should Know About the Pill
10. Most ancient case of tuberculosis found in 500,000-year-old human; points to modern health issues
11. Health Care Districts Board Chair Nationally Recognized as a Modern Healthcare Trustee of the Year
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... recently awarded their ... Eyeglasses . , Millions of individuals in the United States and Canada wear eyeglasses. ... way to both correct vision and make a fashion statement. Even celebrities use glasses ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements owned ... developed to enhance the health of felines. The formula is all-natural and is made ... in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus Root ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, ... and his M.D from the David Geffen School of Medicine at UCLA. He trained ... Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Research and Markets ... Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic ... Coating, Parenteral) - Global Forecast to 2021" report ... The global pharmaceutical excipients market is projected to ... of 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... June 23, 2016 Capricor ... ), a biotechnology company focused on the discovery, ... that patient enrollment in its ongoing randomized HOPE-Duchenne ... exceeded 50% of its 24-patient target. Capricor expects ... third quarter of 2016, and to report top ...
Breaking Medicine Technology: